Products - Dementia | Topic

Showing 3 products

Date | Title

Prevention of dementia
Status:
Awaiting development
Expected publication date:
TBC
Gantenerumab for treating early Alzheimer's disease [TSID10668]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Blarcamesine for treating mild cognitive impairment or mild dementia caused by Alzheimer’s disease [TSID12157]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC